Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Med device maker Doctors Research lands $7.7M

January 7, 2011 6:36 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Doctors Research Group Inc. of Southbury, Conn., a maker of a bone cement for repairing cranial defects, has raised $7.7 million of a planned $15 million financing round, according to a regulatory filing.

Hologic pays $125M to acquire Interlace Medical

January 7, 2011 6:35 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Hologic Inc., a Bedford developer of diagnostics tools for women's health, has acquired Interlace Medical Inc., a Framingham medical device maker, for $125 million.

Airflow Sensor Product Line Expanded With Analog Version

January 7, 2011 6:34 am | Product Releases | Comments

Honeywell announced the introduction of the Honeywell Zephyr Analog Airflow Sensors that provide an analog interface for reading airflow over the specified full scale flow span and temperature range.

Advertisement

Low Resistance LGA Connector Offer Lead-Free Option

January 7, 2011 6:29 am | Product Releases | Comments

In an effort to improve assembly efficiency and reduce the amount of lead content in finished products, many electronics manufacturers have selected a land grid array (LGA) as part of their integrated circuit package.

Chimerix Commences CMX001 Open-Label Clinical Study for the Treatment of Patients With Life-Threatening or Serious dsDNA Viral Infections

January 7, 2011 5:37 am | by Bio-Medicine.Org | News | Comments

RESEARCH TRIANGLE PARK, N.C., Jan. 7, 2011 /- Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today announced that patient enrollment has begun in a multicenter, open-label clinical study of CMX001 (the CMX001-350 study) for the treatment of...

TOPICS:

WaferGen to Present at OneMedForum San Francisco 2011

January 7, 2011 5:37 am | by Bio-Medicine.Org | News | Comments

FREMONT, Calif., Jan. 7, 2011 /- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS ), a leading developer of state-of-the-art genomic analysis systems, today announced that it will present an overview of the company at the 4th Annual OneMedForum Business Development and Investment...

TOPICS:

ADVENTRX Announces Signing of Term Sheet for Acquisition of Poloxamer-Based Therapeutics

January 7, 2011 5:36 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Jan. 7, 2011 /- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX ) today announced that it has signed a term sheet to acquire a private company that holds certain rights and know-how to poloxamer-based therapeutics. The term sheet is non-binding on both ADVENTRX and the target...

TOPICS:

ADVENTRX Pharmaceuticals Announces Capital Raise of $22.5 Million

January 7, 2011 5:36 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Jan. 7, 2011 /- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX ) announced today that it has entered into definitive agreements to sell 8,184,556 units in a registered direct offering to RA Capital Management, certain healthcare-focused investors, and other institutional...

TOPICS:
Advertisement

Amarin Announces Underwriters' Exercise of Over-Allotment Option

January 7, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

MYSTIC, Conn. and DUBLIN, Jan. 7, 2011 /- Amarin Corporation plc (Nasdaq: AMRN ) (the "Company"), a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today announced that, in connection with its previously announced underwritten public offering of American...

TOPICS:

Federal Register: Agency Information Collection Activities; Submission for OMB Review; Comment Request; Medical Devices: Recommended Glossary and Educational Outreach To Suppo...

January 7, 2011 4:31 am | by U.S. Food & Drug Administration | News | Comments

The guidance document provides guidance for the voluntary use of selected symbols in place of text in labeling. It provides the labeling guidance required for: (1) In vitro diagnostic devices (IVDs), intended for professional use under 21 CFR 809.10...

TOPICS:

Hologic buys Interlace for $125 million

January 7, 2011 3:45 am | by The Associated Press | News | Comments

Hologic Inc., which makes mammogram systems and other women's health diagnostic tools, said Friday it bought Interlace Medical Inc. for $125 million in cash, in a move to boost its position in the women's health care market.Interlace, based in Framingham, Mass., makes the MyoSure hysteroscopic...

Chiasma kicks up summer debt round to $5M

January 7, 2011 3:36 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Chiasma Inc., a Newton Center-based biotech, has added to its debt financing round announced last summer, bumping it up from $2 million to $5 million of a planned $6 million, according to federal documents.

Hologic Acquires Interlace Medical

January 7, 2011 2:33 am | by Bio-Medicine.Org | News | Comments

BEDFORD, Mass., Jan. 7, 2011 /- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX ), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today it has acquired...

TOPICS:

LumaSense expands with infrared acquisition

January 7, 2011 1:37 am | by I-Micronews | News | Comments

Camera and sensor company buys L-3 Communications subsidiary InfraredVision Technology Corp.

Carbon nanotubes as optical antennae

January 7, 2011 1:37 am | by I-Micronews | News | Comments

Just as walkie-talkies transmit and receive radio waves, carbon nanotubes can transmit and receive light at the nanoscale, Cornell University researchers have discovered.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading